A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy
Public ClinicalTrials.gov record NCT00535847. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Rollover Protocol of Telaprevir (VX-950) in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Enrolled in the Control Group (Group A) of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Who Did Not Achieve or Maintain an Undetectable HCV RNA Level Through Sustained Viral Response
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To provide access to a telaprevir-based treatment to subjects of the Control Group of Study VX06-950-106 (NCT00420784), VX05-950-104 (NCT00336479), and VX05-950-104EU (NCT00372385) who stopped treatment due to inadequate response to treatment. Safety, tolerability, and Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) levels will be collected.
Study identification
- NCT ID
- NCT00535847
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 117 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2007 (Type not available)
- Primary completion
- Feb 2010 (Actual)
- Completion
- Feb 2010 (Actual)
- Last update posted
- Aug 5, 2014
2007 – 2010
United States locations
- U.S. sites
- 39
- U.S. states
- 23
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Los Angeles | California | — | — |
| Kaiser Permanente Internal Medicine | San Diego | California | — | — |
| Not listed | San Francisco | California | — | — |
| University of Colorado Health Sciences Center | Denver | Colorado | — | — |
| South Denver Gastroenterology | Englewood | Colorado | — | — |
| University of Florida | Gainesville | Florida | — | — |
| Borland-Groover Clinic | Jacksonville | Florida | — | — |
| Mayo Clinic Jacksonville | Jacksonville | Florida | — | — |
| University of Miami Center for Liver Diseases | Miami | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Atlanta Gastroenterology Associates | Atlanta | Georgia | — | — |
| University of Chicago | Chicago | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Digestive and Liver Disease Clinic | Baton Rouge | Louisiana | — | — |
| Virology Treatment Center, Maine Medical Center | Portland | Maine | — | — |
| Johns Hopkins University | Baltimore | Maryland | — | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | — | — |
| University of Massachusetts Memorial Medical Center | Worcester | Massachusetts | — | — |
| Henry Ford Hospital | Detroit | Michigan | — | — |
| St Louis University | St Louis | Missouri | — | — |
| The Nebraska Medical Center | Omaha | Nebraska | — | — |
| University of New Mexico | Albuquerque | New Mexico | — | — |
| North Shore University Hospital | Manhasset | New York | — | — |
| Not listed | New York | New York | — | — |
| Duke University Medical Center | Durham | North Carolina | — | — |
| University of Cincinnati | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Penn State Hershey Medical Center | Hershey | Pennsylvania | — | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | — | — |
| Columbia Gastroenterology Associates, PA | Columbia | South Carolina | — | — |
| Memphis Gastroenterology Group | Germantown | Tennessee | — | — |
| Liver Institute at Methodist Dallas | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Alamo Medical Research | San Antonio | Texas | — | — |
| Not listed | Annandale | Virginia | — | — |
| University of Virginia Health Systems | Charlottesville | Virginia | — | — |
| Metropolitan Research | Fairfax | Virginia | — | — |
| McGuire DVAMC | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00535847, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00535847 live on ClinicalTrials.gov.